<DOC>
	<DOC>NCT01578135</DOC>
	<brief_summary>This study is conducted in Europe. The aim of the study is to describe the patient population and therapeutic practices (study phase I), assess efficacy on growth and adult height and assess tolerance of somatropin (Norditropin® SimpleXx®) (study phase II).</brief_summary>
	<brief_title>French National Registry of Children Born Small for Gestational Age Treated With Somatropin</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Born small for gestational age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>